Form 8-K - Current report:
SEC Accession No. 0001555280-23-000072
Filing Date
2023-02-14
Accepted
2023-02-14 07:05:23
Documents
14
Period of Report
2023-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20230214.htm   iXBRL 8-K 40675
2 EX-99.1 exhibit9912-31x22q4.htm EX-99.1 762846
6 GRAPHIC zoetisca04a01a01a01a01a18a.jpg GRAPHIC 141181
  Complete submission text file 0001555280-23-000072.txt   1180823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20230214.xsd EX-101.SCH 1965
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20230214_lab.xml EX-101.LAB 24132
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20230214_pre.xml EX-101.PRE 12572
8 EXTRACTED XBRL INSTANCE DOCUMENT zts-20230214_htm.xml XML 11352
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 23622255
SIC: 2834 Pharmaceutical Preparations